Physician profile
Jasdeep Manik
NPI 1912324112
$2,384.45
in general payments reported to CMS, 2019-2025
18 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $820 · 2020: $175 · 2021: $221 · 2022: $256 · 2023: $625 · 2024: $175 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $913.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $912.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $482.68 | 2019-2024 | Cequa, Xelpros, Bromsite |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $257.73 | 2019-2021 | |
| Biotissue Holdings INC. | $233.21 | 2021-2025 | |
| Oyster Point Pharma, INC. | $221.21 | 2022-2024 | Tyrvaya |
| Allergan, INC. | $167.38 | 2019 | |
| Bausch & Lomb Americas INC. | $163.88 | 2022-2024 | Vyzulta, Miebo, Lotemax Sm |
| Novartis Pharmaceuticals Corporation | $147.19 | 2019-2023 | |
| Dompe US, INC. | $124.84 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $110.78 | 2019 | |
| Shire North American Group INC | $108.03 | 2019 | |
| Sight Sciences, INC. | $104.36 | 2019-2023 | Tearcare System |
| Kala Pharmaceuticals, INC. | $87.37 | 2019-2022 | |
| Alcon Vision LLC | $47.16 | 2019-2023 | Clareon |
| Ani Pharmaceuticals, INC. | $44.07 | 2023-2024 | Purified Cortrophin Gel |
| Abbvie INC. | $25.00 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $20.55 | 2023 | Iheezo |
| Eyevance Pharmaceuticals LLC | $19.61 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasdeep Manik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.